SERUM BACTERICIDAL ACTIVITY OF RIFAMPIN IN COMBINATION WITH OTHER ANTIMICROBIAL AGENTS AGAINST STAPHYLOCOCCUS-AUREUS

被引:72
作者
HACKBARTH, CJ
CHAMBERS, HF
SANDE, MA
机构
[1] UNIV CALIF SAN FRANCISCO, SCH MED, DEPT MED, SAN FRANCISCO, CA 94143 USA
[2] SAN FRANCISCO GEN HOSP, MED SERV, SAN FRANCISCO, CA 94110 USA
关键词
D O I
10.1128/AAC.29.4.611
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:611 / 613
页数:3
相关论文
共 20 条
[1]   DISPARITY BETWEEN TIMED-KILL AND CHECKERBOARD METHODS FOR DETERMINATION OF INVITRO BACTERICIDAL INTERACTIONS OF VANCOMYCIN PLUS RIFAMPIN VERSUS METHICILLIN-SUSCEPTIBLE AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].
BAYER, AS ;
MORRISON, JO .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :220-223
[2]  
ERICSSON HM, 1971, ACTA PATHOLOG MICROB, P1
[3]   INVITRO ACTIVITY OF CIPROFLOXACIN (BAY O 9867) [J].
FASS, RJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) :568-574
[4]   INVITRO ANTIBACTERIAL ACTIVITY OF 3 NEW QUINOLONE DERIVATIVES - ROSOXACIN, NORFLOXACIN, PEFLOXACIN [J].
HUSSON, MO ;
IZARD, D ;
LECLERC, H .
ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1984, 258 (2-3) :283-286
[5]  
KARCHMER AW, 1983, REV INFECT DIS, V5, pS543
[6]  
KOBASA WD, 1983, REV INFECT DIS, V5, pS533
[7]  
Krogstad D. J., 1980, ANTIBIOTICS LABORATO, P298
[8]   KILLING OF INTRALEUKOCYTIC STAPHYLOCOCCUS-AUREUS BY RIFAMPIN - IN-VITRO AND IN-VIVO STUDIES [J].
MANDELL, GL ;
VEST, TK .
JOURNAL OF INFECTIOUS DISEASES, 1972, 125 (05) :486-&
[9]   TREATMENT OF EXPERIMENTAL STAPHYLOCOCCAL INFECTIONS - EFFECT OF RIFAMPIN ALONE AND IN COMBINATION ON DEVELOPMENT OF RIFAMPIN RESISTANCE [J].
MANDELL, GL ;
MOORMAN, DR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (04) :658-662
[10]  
NORDEN CW, 1983, REV INFECT DIS, V5, pS491